Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
ClinicalTrials.gov · NCT00331851 · Registry updated: 2017-01-26
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Argentina · Austria · Brazil · Denmark · Finland · France · India · Italy · Netherlands · Norway · Philippines · Poland · Russia · Serbia and Montenegro · Slovakia · South Africa · Spain · United Kingdom
- Registry dates and results
- Start: 2006-05. Completion: 2007-04 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- liraglutide (drug)
- insulin glargine (drug)
- metformin (drug)
- glimepiride (drug)
Where the study takes place — 116 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.